BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33937275)

  • 1. Uremic Toxins in Organ Crosstalk.
    Lowenstein J; Nigam SK
    Front Med (Lausanne); 2021; 8():592602. PubMed ID: 33937275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
    Wu W; Bush KT; Nigam SK
    Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.
    Vanholder R; Nigam SK; Burtey S; Glorieux G
    Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.
    Bush KT; Singh P; Nigam SK
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.
    Nigam SK; Wu W; Bush KT; Hoenig MP; Blantz RC; Bhatnagar V
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):2039-49. PubMed ID: 26490509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OAT, OATP, and MRP Drug Transporters and the Remote Sensing and Signaling Theory.
    Nigam SK; Granados JC
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():637-660. PubMed ID: 36206988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.
    Bush KT; Wu W; Lun C; Nigam SK
    J Biol Chem; 2017 Sep; 292(38):15789-15803. PubMed ID: 28765282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
    Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T
    Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renal failure on drug transport and metabolism.
    Sun H; Frassetto L; Benet LZ
    Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression.
    Favretto G; Souza LM; Gregório PC; Cunha RS; Maciel RAP; Sassaki GL; Toledo MG; Pecoits-Filho R; Souza WM; Stinghen AEM
    J Vasc Res; 2017; 54(3):170-179. PubMed ID: 28472795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.
    Jamshidi N; Nigam SK
    Sci Rep; 2022 Oct; 12(1):18308. PubMed ID: 36316339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism.
    Granados JC; Ermakov V; Maity K; Vera DR; Chang G; Nigam SK
    JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36692015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote effects of kidney drug transporter OAT1 on gut microbiome composition and urate homeostasis.
    Ermakov VS; Granados JC; Nigam SK
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The systems biology of uric acid transporters: the role of remote sensing and signaling.
    Nigam SK; Bhatnagar V
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):305-313. PubMed ID: 29847376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of human organic anion as well as cation transporters with indoxyl sulfate.
    Enomoto A; Takeda M; Taki K; Takayama F; Noshiro R; Niwa T; Endou H
    Eur J Pharmacol; 2003 Apr; 466(1-2):13-20. PubMed ID: 12679137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing Molecular Properties of OAT, OATP, and MRP Drug Substrates by Machine Learning.
    Nigam AK; Momper JD; Ojha AA; Nigam SK
    Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.